References with PepMix™ Peptide Pools - Control Pools

2024

2024

    • Multiparametric analysis of the specific immune response against SARS-CoV-2
      Vránová et al., Infectious Diseases (2024) 
      Product used: CEF Pool (extended)
    • Effects of the induction of humoral and cellular immunity by third vaccination for SARS-CoV-2
      Murayama et al., Journal of Infection and Chemotherapy (2024) - PMID: 38570139
      Product used: CEFT Pool 
    • Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine
      Ye et al., Vaccines (2024) - PMID: 38561339
      Product used: PepMix™ HCMVA (pp65)
    • Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8+ T-Cell Proliferation in Patients With Multiple Sclerosis
      Abbadessa et al., Neurolog. Neuroimmunology Neuroinflammation (2024) - PMID: 38662990
      Products used: CEFX Ultra SuperStim Pool
    • The neo-open reading frame peptides that comprise the tumor framome are a rich source of neoantigens for cancer immunotherapy
      Martin et al., Cancer Immunology (2024) 
      Product used: CEFT Pool 
    • Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment
      Keller et al., Nature Communications (2024) 
      Product used: PepMix™ Human (Actin)
    • Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication
      Keller et al., Nature Communications (2024) 
      Product used: PepMix Human (Actin)
    • A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results
      Rappaport et al., Nature Medicine (2024) - PMID: 38538867
      Product used: CEF Pool (standard)
    • Comparable CD8+ T‐cell responses to SARS‐CoV‐2 vaccination in single‐cell transcriptomics of recently allogeneic transplanted patients and healthy individuals
      Tranter et al., Journal of Medical Virology (2024) - PMID: 38516755
      Products used: CEFX Ultra SuperStim Pool, PepMix SARS-CoV-2 (NCAP), SARS-CoV-2 (Spike Glycoprotein SUB1 & SUB2), AP3A (ORF3a), NS7ANS8Pan‐SARS2 select, and custom‐made pools containing cross‐reactive epitopes with spike or without spike and the single peptide S816‐830 (N′‐SFIEDLLFNKVTLAD‐C′)
    • Phase I trial of viral vector based personalized vaccination elicits robust neoantigen specific antitumor T cell responses
      D'Alise et al., Clinical Cancer Research (2024) - PMID: 38506710
      Product used: CEFX Ultra SuperStim Pool
    • Keratinocyte-derived small extracellular vesicles supply antigens for CD1a-resticted T cells and promote their type 2 bias in the context of filaggrin insufficiency
      Kobiela et al., Frontiers in Immunology (2024) - PMID: 38585273
      Product used: CEFT Pool
    • mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses
      Van Den Dijssel et al., Journal of Autoimmunity (2024) - PMID: 38387105
      Product used: CEF Pool (standard)
    • MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans
      Mayer et al., Vaccines (2024) - PMID: 38278816
      Products used: CEF Pool (extended), PepMix™ SARS-CoV-2 (Spike Glycoprotein)
    • Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
      Pant et al., Nature Medicine (2024) - PMID: 38195752
      Products used: PepMix SARS-CoV-2 (S-RBD)CEFSX Ultra SuperStim PoolCEFT Pool, PepMix™ Pan-CMV Select, PepMix CMVA pp65, PepMix™ Pan-EBV SelectCEF Pool (standard)
    • H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patient
      Boschert et al., Science Advances (2024) - PMID: 38306431
      Products used: CEFX Ultra SuperStim Pool
    • Impaired T and "memory-like" NK-cell reconstitution is linked to late-onset HCMV reactivation after letermovir cessation
      Lauruschkat et al., Blood Advances (2024) - PMID: 38315873
      Products used: PepMix™ CMVA (pp65), PepMix™ HIV-1 (NEF) Ultra
    2023

    2023

      • Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
        Pant et al., Nature Medicine (2024) - PMID: 38195752
        Product used: PepMix™ SARS-CoV-2 (S-RBD)CEFSX Ultra SuperStim PoolCEFT PoolPepMix™ Pan-CMV SelectPepMix CMVA pp65PepMix™ Pan-EBV SelectCEF Pool (standard)
      • Photothermal Prussian blue nanoparticles generate potent multi-targeted tumor-specific T cells as an adoptive cell therapy
        Sweeney et al., Bionengineering and Translational Medicine
        Product used: PepMix™ Human (Actin)
      • Charakterisierung von T-Stammzell-Gedächtnis Zellen (TSCM) in verschiedenen Alterkohorten Characterization of T Stem Cell Memory Cells in distinct Age bands
        Hasselmann, Dissertation (2023) 
        Products used: PepMix™ CMVA (pp65)PepMix™ CMVA (IE-1)
      • A novel Shiga toxin 2a neutralizing antibody therapeutic with low immunogenicity and high efficacy
        Kirkland et al., Antimicrobial Agents and Chemotherapy 
        Product used: CEFT PoolPepMix™ Human (MOG)
      • Identification of novel canonical and cryptic HCMV-specific T-cell epitopes for HLA-A*03 and HLA-B*15 via peptide-PRISM
        Rein et al., Blood Advances (2023) 
        Product used: PepMix™ CMVA (pp65)
      • Cytomegalovirus-Specific T Cells in Pediatric Liver Transplant Recipients
        Getsuwan et al., Viruses (2023) 
        Products used: PepMix CMVA (IE-1), PepMix CMVA (pp65)
      • Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy target
        Mandal et al., Nature Cancer (2023) 
        Products used: PepMix EBV (LMP1), EBV (EBNA1), EBV (LMP2), EBV (BZLF1), EBV (BRLF1), PepMix CMVA (pp65), PepMix CMVA (IE-1)
      • Identification and validation of neoepitope-specific T cell receptors for glioma immunotherapy
        Lindner, Dissertation (2023) 
        Product used: CEF Pool (standard)
      • Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results
        Palmer et al., Nature Medicine (2023) - PMID: 35970920
        Product used: CEF Pool (standard)
      • Identifizierung und Charakterisierung antigenspezifischer T-Zell-Antworten gegen Glioblastome
        Lu, Dissertation (2023)
        Products used: human TAAs & CEF Pool (standard)
      • Long-term outcome of progressive multifocal leukoencephalopathy with recombinant interleukin-2 treatment and an associated increase in the number of HPyV-2-specific T-cells: a case report
        Hoff et al., Therapeutic Advances in Hematology (2023) - PMID: 37822572
      • Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELDTM and COVAXIN® induced immunity in COVID-19 exposed Indians
        Rakshit et al., NPJ Vaccines (2023) - PMID: 37709772
        Product used: CEFT Pool
      • U54 SCENT Intracellular Staining (ICS) Senescence Flow Cytometry Panel
        Healy et al., Scent, Protocol
        Products used: CEF Pool (extended)CEFX Ultra SuperStim Pool
      • Ablative radiation alone in stage I lung cancer produces an adaptive systemic immune response: insights from a prospective study
        Voong et al., Journal for ImmunoTherapy of Cancer (2023)
        Products used: CEFX Ultra SuperStim Pool MHC-II Subset PepMix™ HIV-1 (GAG) Ultra
      • Activating Inducible T cell Co-stimulator (ICOS) yields anti-tumor activity alone and in combination with anti-PD-1 checkpoint blockade
        Yadavilli et al., AACR Journals (2023) 
        Products used: CEFT Pool 
      • Exercise mobilizes diverse antigen specific T-cells and elevates neutralizing antibodies in humans with natural immunity to SARS CoV-2
        Baker et al., Brain Behaviour & Immunity (2023) - PMID: 36743994
        Products used: PepMix Human (Actin) & SARS-CoV-2 (Spike Glycoprotein)
      • CD40 ligand stimulation affects the number and memory phenotypes of human peripheral CD8+ T cells
        Choi et al., BMC Immunology (2023) - PMID: 37391734
        Product used: PepMix CMVA (pp65)
      • GRT-R910: a self-amplifying mRNA SARSCoV-2 vaccine boosts immunity for ≥6months in previously-vaccinated older adults
        Palmer et al., Nature Communications (2023) - PMID: 37280238
        Product used: CEF Pool (standard) 
      • Antigen specificities of HIV-infected cells: A role in infection and persistence?
        Faua et al., Journal of Virus Eradication (2023) 
        Product used: CEFT MHC-II Pool & PepMix CMVA (pp65)
      • The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients
        Friedrich et al., Cancer Cell (2023) - PMID: 36898378
        Product used: CEFT Pool
      • Comparison of intracellular cytokine staining versus an ELISA‐based assay to assess CMV‐specific cell‐mediated immunity in high‐risk kidney transplant recipients
        Fernández‐Ruiz et al., Journal of Medical Virology (2023)
        Product used: PepMix HCMVA (pp65)
      • Untersuchungen zur Kreuzreaktivität von Cytomegalievirusspezifischen T-Lymphozyten und Tumorassoziierten Antigenen
        Weiß, Dissertation (2023)
        Products used: PepMix CMVA (pp65)Human (Mucin-1)Human (NY-ESO-1),  Human (Prame/OIP4) & Human (WT1/WT33)
      • Validation of the performance and suitability of a new class of FBS optimized for use in single-cell functional assays
        Berrong et al., Journal of Immunological Methods (2023) - PMID: 36858170
        Product used: CEF Pool (extended)CEFT MHC-II Pool & PepMix™ CMVA (pp65)
      • Cardiac antigen derived T cell epitopes in the frame of myocardial infarction
        Hapke et al., Dissertation (2023)
      • Age-related Differences in Immune Reactions to SARS-CoV-2 Spike and Nucleocapsid Antigens
        Morhart et al,. In Vivo (2023)
        Products used: PepMix CEFX Ultra SuperStim Pool & PepMix Human (Actin)
      • Diminished responses to mRNA-based SARS-CoV-2 vaccines in individuals with rheumatoid arthritis on immune modifying therapies
        Klebanoff et al., MedRxiv (2023) 
        Products used: CEFX Ultra SuperStim Pool & PepMix SARS-CoV-2 (Spike Glycoprotein)
      Archive

      Archive

      • Filaggrin insufficiency renders keratinocyte-derived small extracellular vesicles capable of modulating CD1a-mediated T cell responses
        Kobiela et al., Research Square (2022) 
        Product used: CEFT Pool
      • Immune Response after the Fourth of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses' Vaccinated Solid Organ Transplant Recipients
        Busà et al,. Vaccines (2022) - PMID: 36298854
        Products used: PepMix SARS-CoV-2 (Spike Glycoprotein)SARS-CoV-2 (NCAP) and CEFX Ultra SuperStim Pool
      • Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer
        Awad et al., Cancer Cell (2022) - PMID: 36027916
        Product used: PepMix CEF Pool (extended)
      • Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results
        Palmer et al., Nature Medicine (2022)
        Product used: PepMix CEF Pool (standard)
      • Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine
        Naaber et al., Cell Reports Medicine (2022) 
        Product used: PepMix CEFX Ultra Super Stim Pool
      • Brief Research Report: Anti-SARS-CoV-2 Immunity in Long Lasting Responders to Cancer Immunotherapy Through mRNA-Based COVID-19 Vaccination
        Sistere-Oro et al., Frontiers in Immunology (2022) 
        Product used: PepMix CEF Pool Standard
      • Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine
        Weskamm et al., Cell Reports Medicine (2022) - PMID: 35858586
        Product used: PepMix CEF Pool (extended)
      • Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study
        Tut et al., The Lancet (2022) 
        Product used: PepMix CEFX Ultra SuperStim Pool 
      • An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors
        Fucikova et al., Clinical Cancer Research (2022) - PMID: 35536547
        Product used: PepMix CEFT Pool
      • Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency
        Campbell et al., Journal of Experimental Medicine (2022) - PMID: 35670811
        Products used:  PepMix CEFX Ultra SuperStim Pool, PepMix CMVA (IE-1 , IE-2 & pp65),
      • Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection
        Tut et al., Nature Aging (2022)
      • Distinct phenotypic states and spatial distribution of CD8+ T cell clonotypes in human brain metastases
        Sudmeier et al., Cell Reports Medicine (2022)
        Product used: PepMix CEFX Ultra SuperStim Pool
      • Landscape of helper and regulatory antitumour CD4+ T cells in melanoma
        Oliveira et al., Nature (2022) - PMID: 35508657
      • Protective antibodies and T cell responses to Omicron variant three months after the booster dose of BNT162b2 vaccine
        Naaber et al., MedRxiv (2022) 
        Product used: CEFX Ultra SuperStim Pool
      • Broad SARS-CoV-2 spike-specific CD4+ T-cell response preserves recognition of variants of concern
        Long et al., Research Square (2022) 
        Product used: CEFX Ultra SuperStim Pool MHC-II Subset
      • Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity
        Rodda et al., MedRxiv (2022) 
        Products used: CEFX Ultra SuperStim Pool
      • A Co-stimulatory CAR Improves TCR-based Cancer Immunotherapy
        Omer et al., Cancer Immunology (2022) - PMID: 35176142
      • Development of an effective immune response in adults with Down Syndrome 2 after SARS-CoV-2 vaccination
        Esparcia-Pinedo et al., MedRxiv (2022)
        Products used: PepMix™ Human (Actin)
      • T-cells of invasive candidiasis patients show patterns of T-cell-exhaustion suggesting checkpoint blockade as treatment option
        Sibylle C.Mellinghoff et al., MedRxiv (2021) - PMID: 34921845 
      • TGM4: An Immunogenic Prostate-Restricted Antigen
        Lopez-Bujanda, Z.A. et al., J Immunother Cancer (2021) 
      • Anti-CD38 Therapy Impairs SARS-CoV-2 Vaccine Response in Multiple Myeloma Patients
        S. Henriquez et al., medRxiv, (2021) 
      • Acute Exercise Increases Immune Responses to SARS CoV-2 in a Previously Infected Man
        Baker, F.L. et al., Brain Behav Immun Health (2021) 
      • Dynamics of Antibody Response to BNT162b2 Vaccine After Six Months: a Longitudinal Prospective Study
        Naaber, Paul et al., Lancet Reg Health Eur, (2021) 
      • Identification of a Class of Non-Conventional ER-Stress-Response-Derived Immunogenic Peptides
        Melacarne, Alessia et al., Cell Rep, (2021) 
      • Adaptive Subsets Limit the Anti-Tumoral NK-Cell Activity in Hepatocellular Carcinoma
        Rennert, Charlotte et al., Cells, (2021) 
      • Monitoring Cell-Mediated Immune Responses in AAV Gene Therapy Clinical Trials Using a Validated IFN-γ ELISpot Method
        Patton, K.S. et al., Mol Ther Methods Clin Dev, (2021) 
      • Gene Transfer in Adeno-Associated Virus Seropositive Rhesus Macaques Following Rapamycin Treatment and Subcutaneous Delivery of AAV6, but Not Retargeted AAV6 Vectors
        Stone, Daniel et al., Human Gene Ther, (2021) 
      • Identification of Neoantigen-Reactive T Lymphocytes in the Peripheral Blood of a Patient With Glioblastoma
        Leko, V. et al., J Immunother Cancer, (2021) 
      • Circulatory Follicular Helper T Lymphocytes Associate With Lower Incidence of CMV Infection in Kidney Transplant Recipients
        Suàrez-Fernández, P. et al., Am J Transplant, (2021) 
      • A Glimpse into the Diverse Cellular Immunity Against SARS-CoV-2
        Chang, Cheng-Wei et al., Vacinnes, (2021) 
      • Tick-Borne Encephalitis Specific Lymphocyte Response after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Humoral Immunity after Vaccination
        Harrison, Nicole et al., Vaccines, (2021) 
      • HIV-Specific T Cell Responses Reflect Substantive in Vivo Interactions With Antigen Despite Long-Term Therapy
        Stevenson, E.M. et al., JCI Insight, (2021) 
      • Identification of Naturally Processed Zika Virus Peptides by Mass Spectrometry and Validation of Memory T Cell Recall Responses in Zika Convalescent Subjects
        Crooke, S.N. et al., PLoS One, (2021)
      • Pre-Transplant Cytomegalovirus-Specific Cellular Immunity and Risk of Viral Reactivation Following Lung Transplantation: a Prospective Cohort Study
        Mohammed Altaf et al., J Infect Dis. (2020) - PMID: 33274385 
      • Gating Harmonization Guidelines for Intracellular Cytokine Staining Validated in Second International Multiconsortia Proficiency Panel Conducted by Cancer Immunotherapy Consortium (CIC/CRI)
        Leah S. Price et al., Journal of Quantitative Cell Science (2020) - PMID: 33090656 
      • Microwave Ablation Enhances Tumor‑Specific Immune Response In Patients With Hepatocellular Carcinoma
        Katharina Leuchte et al., Cancer Immunology, Immunotherapy (2020) - PMID: 33006650 
      • A Glimpse Into the Diverse Cellular Immunity Against SARS-CoV-2
        Lung-Ji Chang et al., Research Square (2020) - PMID: n.a. 
      • Safety and Immunogenicity of a Modified Vaccinia Virus Ankara Vector Vaccine Candidate for Middle East Respiratory Syndrome: an Open-Label, Phase 1 Trial
        Koch et al., Lancet (2020) - PMID: 32325037 
      • Concurrent Human Antibody and TH1 Type T-Cell Responses 2 Elicited by a COVID-19 RNA Vaccine
        Sahin et al., medRXiv (2020) 
      • Safety and Immunogenicity Of a Modified Vaccinia Virus Ankara Vector Vaccine Candidate For Middle East Respiratory Syndrome: An Open-Label, Phase 1 Trial
        Till Koch et al., The Lancet Infectious Diseases (2020) - PMID: 32325037 
      • CMV-Reactive NK Cells in Pediatric Post-Hematopoietic Stem Cell Transplant
        Nopporn Apiwattanakul et al., Transplantation Proceedings (2020) - PMID: 31870602 
      • Magnitude and Functional Profile of the Human CD4+ T Cell Response throughout Primary Immunization with Tick-Borne Encephalitis Virus Vaccine
        Renata Varnaite et al., The Journal of Immunology (2020) - PMID: 31924650 
      • Antigen Responsive CD4+T Cell Clones Contribute to the HIV-1 Latent Reservoir
        Pilar Mendoza et al., bioRxiv (2020) - PMID: n.a.
      • Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms
        Cansu Cimen Bozkus et al., Cancer Discovery (2019) - PMID: 31266769
      • Antigenspezifische T-Lymphozytenantworten als Immunmarker in Verschiedenen Varianten der Chronisch Inflammatorisch Demyelinsierenden Polyneuropathie
        Jan Markus Diederich et al., Klinik für Neurologie mit Experimenteller Neurologie (2019) - PMID: n.a.
      • CD154‐Expressing CMV‐Specific T Cells Associate with Freedom from DNAemia and May be Protective in Seronegative Recipients After Liver or Intestine Transplantation
        Chethan Ashokkumar et al., Wiley (2019) - PMID: n.a.
      • Extracellular pH Modulating Injectable Gel for Enhancing Immune Checkpoint Inhibitor Therapy
        Hyung-seung Jin et al., Journal of Controlled Release (2019) - PMID: 31669264
      • CD38 bright CD8+ T-cells Associated with the Development of Acute GVHD are Activated, Proliferating, and Cytotoxic Trafficking Cells
        Pooja Khandelwal et al., Biology of Blood and Marrow Transplantation (2019) - PMID: 31442594
      • Qualification of an IFN-g Elispot Assay in the Bioanalytical Laborator
        W. Adamowicz et al., Poster#W1130-04-02 (2019) - PMID: n.a.
      • CNS Antigen-Specific B Cell and Antibody Assays in Multiple Sclerosis
        Kuerten et al., United States Patent Application 20190072551 (2019) - PMID: n.a.
      • Leukoreduction System Chambers are a Reliable Cellular Source for the
        Manufacturing of T‐Cell Therapeutics
        Gabrielle Boudreau et al., Transfusion (2018) - PMID: 30589447
      • Semi-Static Cell Culture
        Molleryd et al., US Patent App. 15/574,003 (2018) - PMID: n.a.
      • Bi-Specific Targeted Chimeric Antigen Receptor T Cells
        Wang et al., US Patent App. 15/561,921, 2018 (2018) - PMID: n.a.
      • Human Lymph Nodes Maintain TCF-1hi Memory T Cells with High Functional Potential and Clonal Diversity throughout Life
        Miron et al., J Immunol (2018) - PMID: 30111633
      • Reversibility of Peripheral Blood Leukocyte Phenotypic and Functional Changes after Exposure to and Withdrawal from Tofacitinib, a Janus Kinase Inhibitor, in Healthy Volunteers
        Weinhold et al., Clin. Immunol (2018) - PMID: 29518577
      • Human Cytomegalovirus-Specific Memory CD4+ T-cell Response and its Correlation with Virus Transmission to the Fetus in Pregnant Women with Primary Infection
        Fornara et al., J Infect Dis. (2017) - PMID: 17330798
      • The Effect of Genetic Variants Affecting NK Cell Function on Cardiovascular Health and the Burden on CMV
        Waters S et al., Hum Immunol (2017) - PMID: 28987961
      • Intradermal HIV-1 DNA Immunization Using Needle-free Zetajet TM Injection Followed by HIV-modified Vaccinia Virus Ankara Vaccination is Safe and Immunogenic in Mozambican Young Adults: a Phase I Randomized Controlled Trial
        Viegas et al., AIDS Res Hum Retroviruses (2017) - PMID: 28969431
      • CMV Drives the Expansion of Highly Functional Memory T Cells Expressing NK-Cell Receptors in Renal Transplant Recipients
        Makwana et al., European Journal of Immunology (2017) - PMID: 28586095
      • CMV Specific T-Cell Immunity in Solid Organ Transplant Recipients at Low Risk of CMV Infection. Chronology and Aplicability in Preemptive Therapy
        Mena-Romo et al., Journal of Infection (2017) - PMID: 28599954
      • Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy
        Tsai et al., Journal of Virology (2017) - PMID: 28179531
      • Generation of Dendritic Cell-based Vaccine Using High Hydrostatic Pressure for Non-small Cell Lung Cancer Immunotherapy
        Hradilova et al., Plos One (2017) - PMID: 28187172
      • Phase II Trial of Albumin-Bound Paclitaxel and Granulocyte Macrophage Colony-Stimulating Factor as an Immune Modulator in Recurrent Platinum Resistant Ovarian Cancer
        Liaoa et al., Gynecologic Oncology (2017) - PMID: 28089377
      • Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein–Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients
        Hui et al., Cancer Research (2016) - PMID: 23348421
      • Individuals with Inherited Chromosomally Integrated Human Herpes Virus 6 (ciHHV-6) Have Functionally Active HHV-6 Specific T-cell Immunity
        Strenger et al., Clinical Microbiology and Infection (2016) - PMID: 26482270
      • Human Parainfluenza Virus-3 Can be Targeted by Rapidly Ex Vivo Expanded T Lymphocytes
        McLaughlin et al., Cytotherapy (2016) - PMID: 27692559
      • A Fully Human IgG1 Anti-PD-L1 MAb in an In Vitro Assay Enhances Antigen-Specific T-Cell Responses
        Grenga et al., Clinical & Translational Immunology (2016) - PMID: n.a.
      • Efficacy and Safety of a Preemptive Antiviral Therapy Strategy Based on Combined Virological and Immunological Monitoring for Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant Recipients
        Navarro et al., Oxford Jounals (2016) - PMID: n.a.
      • Stoke Induces Specific Alteration of T Memory Compartment Controlling Auto-Reactive CNS Antigen-Specific T Cell Responses
        Klehmet et al., Journal of the Neurological (2016) - PMID: n.a.
      • Stabilization of Pre‐optimized Multicolor Antibody Cocktails for Flow Cytometry Applications
        Chan et al., Cytometry Part B: Clinical Cytometry (2016) - PMID: 27001933
      • How Frequently Are Predicted Peptides Actually Recognized by CD8 Cells?
        Moldovan et al., Cancer Immunol Immunother. (2016) - PMID: 27108305
      • RNA Vaccination Therapy: Advances in an Emerging Field
        Thielemans et al., Journal of Immunology Research (2016) - PMID: n.a.
      • Impact of Persistent Cytomegalovirus Infection on Dynamic Changes in Human Immune System Profile
        Vescovini et al., PlosOne - PMID: 26990192
      • Standardization of Cryopreserved Peripheral Blood Mononuclear Cells Through a Resting Process for Clinical Immunomonitoring—Development of an Algorithm
        Wang et al., Cytometry A. (2015) - PMID: 26848928
      • Dichotomous Effects of Latent CMV Infection on the Phenotype and Functional Properties of CD8+ T-cells and NK-cells
        Bigley et al., Cellular Immunology (2015) - PMID: n.a
      • Combined PI3K/Akt and Hsp90 Targeting Synergistically Suppresses Essential Functions of Alloreactive T Cells and Increases Tregs
        Berges et al., J. Leukoc. Biol. (2015) - PMID: 26265781
      • K562-Derived Whole-Cell Vaccine Enhances Antitumor Responses of CAR-Redirected Virus-Specific Cytotoxic T Lymphocytes In Vivo
        Caruana et al., Clin Cancer Res. (2015) - PMID: 25691731
      • Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients
        Xu et al., Am J Transplant. (2015) - PMID: 26436448
      • Latent CMV Infection in Rheumatoid Arthritis Increases Frequencies of cytolytic LIR‐1+ CD8+ T Cells
        Rothe et al., Arthritis Rheumatol. (2015) - PMID: 26314621
      • Self-adjuvanted mRNA Vaccination in Advanced Prostate Cancer Patients: a First-in-Man Phase I/IIa Study
        Kübler et al., J Immunother Cancer. (2015) - PMID: 26082837
      • Guidelines For the Automated Evaluation of Elispot Assays
        Janetzki et al., Nature Protocols (2015) - PMID: 26110715
      • The Transcriptional PPARβ/ Network in Human Macrophages Defines a Unique Agonist-induced Activation State
        Adhikary et al., Nucleic Acids Res.(2015) - PMID: 25934804
      • Development of a Novel IGRA Assay to Test T Cell Responsiveness to HBV Antigens in Whole Blood of Chronic Hepatitis B Patients
        Dammermann et al., J Transl Med. (2015) - PMID: 25968473
      • Profiling T Cell Activation Using Single-Molecule Fluorescence In Situ Hybridization and Flow Cytometry
        Bushkin et al., J. Immunol. (2015) - PMID: 25505292
      • Identification and HLA-Tetramer-Validation of Human [CD4.sup.+] and [CD8.sup.+] T Cell Responses Against HCMV Proteins IE1 and IE2
        Peter Braendstrup et al., PLoS ONE (2014) - PMID: 24760079
      • Cognate CD4 T-Cell Licensing of Dendritic Cells Heralds Anti-CMV CD8 T-Cell Immunity After Human Allogeneic Umbilical Cord Blood Transplantation
        Flinsenberg et al., J Virol. (2014) - PMID: 25378489
      • T-bet:Eomes Balance, Effector Function, and Proliferation of Cytomegalovirus-specific CD8+ T Cells During Primary Infection Differentiates the Capacity for Durable Immune Control
        Popescu et al., J Immunol. (2014) - PMID: 25339676
      • Polyfunctional Analysis of Human Cytomegalovirus (HCMV)-Specific CD4+ and CD8+ Memory T-Cells in HCMV-Seropositive Healthy Subjects Following Different Stimuli
        Gabanti et al., J Clin Immunol. (2014) - PMID: 25231588
      • Toward Development of a Comprehensive External Quality Assurance Program for Polyfunctional Intracellular Cytokine Staining Assays
        Staats et al., J Immunol Methods. (2014) - PMID: 24968072
      • Viral Load, CMV-Specific T Cell Immune Response and Cytomegalovirus Disease in Solid Organ Transplant Recipients at Higher Risk for Cytomegalovirus Infection During Preemptive Therapy
        Martín-Gandul et al., Transpl Int. (2014) - PMID: 24964364
      • A Registry of HLA-Typed Donors for Production of Virus-Specific CD4 and CD8 T Lymphocytes for Adoptive Reconstitution of Immune-compromised Patients
        Pira et al., Transfusion. (2014) - PMID: 25041366
      • Frequent Occurrence of Cytomegalovirus Retinitis During Immune Reconstitution Warrants Regular Ophthalmic Screening in High-Risk Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients
        Hiwarkar et al., Clinical Infectious Diseases (2014) - PMID: 24700657
      • Increased Inflammatory Response in Cytomegalovirus Seropositive Patients with Alzheimer's Disease
        Westmann et al., Plos One (2014) - PMID: 24804776
      • Identification and HLA-Tetramer-Validation of Human CD4+ and CD8+ T Cell Responses Against HCMV Proteins IE1 and IE2
        Braendstrup et al., PLOS ONE (2014) - PMID: 24760079
      • Timing and Intensity of Exposure to Interferon‐gamma Critically Determines the Function of Monocyte‐derived Dendritic Cells
        Kerkar et al., Immunology (2014) - PMID: 24678989
      • Day 3 Poly (I: C)-Activated Dendritic Cells Generated in CellGro for Use in Cancer Immunotherapy Trials are Fully Comparable to Standard Day 5 DCs
        Truxova et al., Immunology Letters (2014) - PMID: 24726860
      • Immunologic Response to the Survivin-Derived Multi-Epitope Vaccine EMD640744 in Patients with Advanced Solid Tumors
        Lennerz er al., Cancer Immunol Immunothert (2014) - PMID: 24487961
      • Miniaturized and High Throughput Assays for Analysis of T-Cell Responses Specific for Opportunistic Pathogens and HIV
        Li Pira et al., Clin Vaccine Immunol. (2014) - PMID: 24477854
      • The Allo- and Viral-Specific Immunosuppressive Effect of Belatacept, but Not Tacrolimus, Attenuates with Progressive T Cell Maturation
        Xu er al., Am. J. Transplant (2014) - PMID: 24472192
      • Statistical Methods for the Assessment of EQAPOL Proficiency Testing: ELISpot, Luminex, and Flow Cytometry
        Rountree et al., J. Immunol Methods (2014) - PMID: 24456626
      • Evaluation of Cytomegalovirus (CMV)-Specific T-Cell Immunity for the Assessment of the Risk of Active CMV Infection in Non-Immunosuppressed Surgical and Trauma Intensive Care Unit Patients
        Clari et al., J. Med Virol. (2013) - PMID: 23868746
      • Immunotherapeutic Strategies to Prevent and Treat Human Herpesvirus 6 Reactivation after Allogeneic Stem Cell Transplantation
        Gerdemann et al. (2013) - PMID: 23152545
      • Lymphocyte Activation Gene-3 Expression Defines a Discrete Subset of HIV-Specific CD8+ T Cells That Is Associated with Lower Viral Load
        Peña et al., AIDS Res Hum Retroviruses (2013) - PMID: 24180338
      • Cytomegalovirus-Specific Cytotoxic T Lymphocytes Can Be Efficiently Expanded from Granulocyte Colony-Stimulating Factor–Mobilized Hemopoietic Progenitor Cell Products Ex Vivo and Safely Transferred to Stem Cell Transplantation Recipients to Facilitate Imm
        Clancy et al., Biology Blood Marrow Transplant (2013) - PMID: 23380344
      • Broad and Potent Cellular and Humoral Immune Responses After a Second Late HIV-Modified Vaccinia Virus Ankara Vaccination in HIV-DNA-Primed and HIV-Modified Vaccinia Virus Ankara-Boosted Swedish Vaccinees
        Nilsson et al., AIDS Res Hum Retroviruses (2013) - PMID: 24090081
      • Combining Next-Generation Sequencing and Immune Assays: A Novel Method for Identification of Antigen-Specific T Cells
        Klinger et al., PLoS One (2013) - PMID: 24069285
      • Single-Cell Level Response of HIV-Specific and Cytomegalovirus-Specific CD4 T Cells Correlate With Viral Control in Chronic HIV-1 Subtype A Infection
        Eller et al., J. Acquir Immune Defic Syndr (2012) - PMID: 22580564
      • A New Antigen Scanning Strategy for Monitoring HIV-1 Specific T-cell Immune Responses
        Manati et al., Journal of Immunological Methods (2012) - PMID: 21963950
      • Polyfunctional T Cells Accumulate in Large Human Cytomegalovirus-Specific T Cell Responses
        Lachmann et al., J. Virol. (2012) - PMID: 22072753
      • Innate and Adaptive Immune Responses Both Contribute to Pathological CD4 T Cell Activation in HIV-1 Infected Ugandans
        Eller et al., PLoS ONE (2011) - PMID: 21526194
      • Correlating Cellular and Molecular Signatures of Mucosal Immunity that Distinguish HIV Controllers from Non-Controllers
        Loke et al., Blood (2011) - PMID: 20160163
      • Generation of a Multipathogen-Specific T-cell Product for Adoptive Immunotherapy Based on Activation-Dependent Expression of CD154
        Khanna et al., Blood (2011) - PMID: 21642594
      • A Panel of Human Cell-Based Artificial APC Enables the Expansion of Long-Lived Antigen-Specific CD4+ T Cells Restricted by Prevalent HLA-DR Alleles
        Butler et al., Int. Immunol. (2010) - PMID: 21059769
      • AdCD40L Immunogene Therapy for Bladder Carcinoma—The First Phase I/IIa Trial
        Malmström et al., Clin. Cancer Res. (2010) - PMID: 20448220
      • Intense Antiextracellular Adaptive Immune Response to Human Cytomegalovirus in Very Old Subjects with Impaired Health and Cognitive and Functional Status
        Vescovini et al., J. Immunol. (2010) - PMID: 20173031
      • Human Late Memory CD8+ T Cells Have a Distinct Cytokine Signature Characterized by CC Chemokine Production without IL-2 Production
        St. Johns et al., J. Immunol. (2009) - PMID: 19841187
      • The Transfer of Adaptive Immunity to Cytomegalovirus (CMV) During Hematopoietic Stem Cell Transplantation is Dependent on the Specificity and Phenotype of CMV-Specific T Cells in the Donor
        Scheinberg et al., Blood (2009) - PMID: 19776383
      • T Cell Infiltrates in the Muscles of Patients with Dermatomyositis and Polymyositis Are Dominated by CD28null T Cells
        Fasth et al., J. Immunol. (2009) - PMID: 19752224
      • Identification and Characterization of IL-10/IFN-gamma-Producing Effector-Like T cells with Regulatory Function in Human Blood
        Haringer et al., J. Exp. Med. (2009) - PMID: 19414553
      • Enumeration of Cytomegalovirus-Specific Interfering CD8+ and CD4+ T Cells Early After Allogeneic Stem Cell Transplantation May Identify Patients at Risk of Active Cytomegalovirus Infection
        Solano et al., Haematologica (2008) - PMID: 18603553
      • Clonotype Analysis of Cytomegalovirus-Specific Cytotoxic T Lymphocytes
        Babel et al., JASN Express (2008) - PMID: 18799721
      • Type I IFN-Induced, NKT Cell-Mediated Negative Control of CD8 T Cell Priming by Dendritic Cells1
        Bochtler et al., The Journal of Immunology (2008) - PMID: 18641299
      • Prophylactic Infusion of Cytomegalovirus Specific Cytotoxic T-lymphocytes Stimulated with Ad5f35pp65 Gene Modified Dendritic Cells Following Allogeneic Haemopoietic Stem Cell Transplantation
        Micklethwaite et al., Blood (2008) - PMID: 18768783
      • Massive Load of Functional Effector CD4+ and CD8+ T Cells against Cytomegalovirus in Very Old Subjects
        Viscovini et al., J Immunol. (2007) - PMID: 17785869
      • Longitudinal Assessment of Cytomegalovirus (CMV)–Specific Immune Responses in Liver Transplant Recipients at High Risk for Late CMV disease
        La Rosa et al., The Journal of Infectious Diseases (2007) - PMID: 17262704
      • No Evidence for Circulating HuD-Specific CD8+ T Cells in Patients with Paraneoplastic Neurological Syndromes and Hu Antibodies
        De Beukelaar et al., Cancer Immunol Immunother (2007) - PMID: 17597332
      • The T Cell Response to Persistent Herpes Virus Infections in Common Variable Immunodeficiency
        Raeiszadeh et al., British Society for Immunology, Clinical and Experimental Immunology (2006) - PMID: 17034575
      • Monoculture-Derived T lymphocytes Specific for Multiple Viruses Expand and Produce Clinically Relevant Effects in Immunocompromised Individuals
        Leen et al., Nature Medicine (2006) - PMID: 16998485
      • Direct Access to CD4+ T Cells Specific for Defined Antigens According to CD154 Expression
        Frentsch et al., Nat Med. (2005) - PMID: 16186818
      • HLA Type-Independent Generation of Antigen-Specific T Cells for Adoptive Immunotherapy
        Hammer et al., Eur. J. Immunol. (2005) - PMID: 16468975
      Loading...

      Check our list of products, click and go.

      Get a quote